Current recommendations for the prevention and treatment of influenza in the older population.
Influenza is a major cause of morbidity and mortality in the elderly. Influenza vaccine is recommended for people aged 65 years and older and those in long term care. Currently only 30% of high risk persons are vaccinated. Vaccination generally stimulates an adequate immune response, is well tolerated and is to be encouraged. Prophylactic amantadine 100 mg/day should be given for 2 weeks with influenza vaccine in the aged population when they have not been previously immunised. Broad application of these preventive measures would have a significant impact on reducing influenza prevalence in the elderly and other high risk groups.
Gross
P A
PA
Department of Internal Medicine, Hackensack Medical Center, New Jersey.
D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D007252:Influenza Vaccines / Q000276:immunology; D007251:Influenza, Human / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control*; D009975:Orthomyxoviridae / Q000235:genetics
D000998:Antiviral Agents; D007252:Influenza Vaccines